Today: 20 May 2026
Verizon stock today: VZ edges higher as traders eye Jan. 30 earnings and dividend
31 December 2025
2 mins read

Verizon stock today: VZ edges higher as traders eye Jan. 30 earnings and dividend

NEW YORK, December 31, 2025, 15:31 ET — Regular session

  • Verizon shares were up about 0.5% in afternoon trade on the final U.S. session of 2025.
  • The carrier has set January 30 for its fourth-quarter results and webcast.
  • Investors are watching dividends and interest-rate signals as year-end rebalancing wraps up.

Verizon Communications Inc shares rose 0.5% to $40.90 in afternoon trading on Wednesday, after moving between $40.62 and $40.96 earlier in the session. About 9.6 million shares had changed hands.

The modest move still drew attention because it came during thin, year-end trading, when portfolio rebalancing can push steady, high-dividend names away from the market’s broader drift.

It also puts focus on the next scheduled catalyst: Verizon said it will report fourth-quarter 2025 earnings on Friday, Jan. 30, 2026, and host a webcast beginning at 8:00 a.m. ET. The company said it will post materials, including its press release and financial tables, at 6:30 a.m. ET on its investor relations website.

Verizon’s move roughly tracked AT&T, which was up about 0.5%, while T-Mobile US was down about 0.1% in afternoon trade. The trio often trades as a group when investors focus on pricing competition and subscriber trends in U.S. wireless.

The broader backdrop was subdued. Wall Street’s major indexes were slightly lower in the final trading session of 2025, with volumes thin in the holiday-shortened week and markets closed on Thursday for New Year’s Day, Reuters reported.

Strategists have described the late-December churn as routine rather than directional. “It’s just a healthy rebalancing of allocations,” said Mark Hackett, chief market strategist at Nationwide, as investors look ahead to the Federal Reserve’s Jan. 27–28 meeting, where markets expect policymakers to leave rates unchanged. Reuters

For Verizon, the dividend remains central to the stock’s appeal. The company’s board declared a quarterly dividend of 69 cents per share in early December, payable Feb. 2 to shareholders of record as of Jan. 12.

With shares around $41, that payout implies an annualized dividend yield of about 6.8%. Dividend yield is the annual cash dividend divided by the stock price, and it tends to matter more when investors are comparing income stocks to bond returns.

When Verizon reports next month, investors will look for management’s read on wireless pricing and postpaid phone net additions. Postpaid customers pay after using service and are typically viewed as a stickier base than prepaid users.

Free cash flow will be another key watchpoint because it underwrites the dividend and supports debt reduction. Any changes to capital spending plans for 5G and fiber can move that number quickly.

Investors will also be listening for updates on strategy under Chief Executive Dan Schulman, who took over in October, and on the company’s planned acquisition of Frontier Communications, which Verizon has said is expected to close in the first quarter of 2026.

Until earnings, Verizon is likely to trade like a bond proxy — meaning its price can swing with interest-rate expectations because a large portion of its return comes from cash payouts rather than rapid growth.

The next major checkpoint for traders is Jan. 30, when Verizon updates investors on results, cash generation and competitive conditions heading into 2026.

Stock Market Today

  • Understanding Level 2 Order Book in Stock Trading
    May 20, 2026, 5:26 AM EDT. Level 2 Order Book reveals market makers' buy and sell prices, offering insights into supply and demand dynamics. It shows whether buying or selling orders dominate, helping predict short-term price movements. Traders use this tool to gauge potential shifts and execute informed decisions. Access to Level 2 data can enhance market transparency and trading strategy effectiveness.

Latest articles

Marvell Stock Is Heating Up Again Before Earnings — The AI Chip Bet Gets One More Test

Marvell Stock Is Heating Up Again Before Earnings — The AI Chip Bet Gets One More Test

20 May 2026
Marvell Technology shares rose 4.53% to $184.25 in premarket trading Wednesday, extending Tuesday’s 4.35% gain. The company will report fiscal Q1 2027 results after the close on May 27. Analysts at Evercore ISI, Melius Research, and CLSA raised price targets, citing strong demand for custom AI chips. Marvell posted record fiscal 2026 revenue of $8.195 billion in March.
SpaceX restarts Starlink launches after satellite mishap — and another Falcon 9 is already queued

SpaceX IPO Moves Closer as Goldman Nears Top Role in $1.75 Trillion Listing

20 May 2026
Goldman Sachs is set to lead SpaceX’s planned IPO, which could become the largest in history, with a targeted valuation of about $1.75 trillion, Reuters reported. SpaceX aims to publish its prospectus as soon as Wednesday and list on Nasdaq under the ticker SPCX as early as June 12. The company’s next Starship test flight is scheduled for May 21 from Texas. Morgan Stanley, Bank of America, Citigroup, and JPMorgan are also expected to play major roles.
Nvidia Earnings Test Seen as Key $355 Billion Moment for Wall Street AI Traders

Nvidia Earnings Test Seen as Key $355 Billion Moment for Wall Street AI Traders

20 May 2026
Options pricing signals traders expect a 6.5% swing in Nvidia shares, or about $355 billion in market value, after Wednesday’s earnings. The stock closed Tuesday at $220.61, valuing Nvidia at $5.4 trillion. Wall Street consensus sees quarterly revenue at $78.5 billion, with data-center sales at $72.8 billion. Competitors AMD, Intel, and Alphabet are challenging Nvidia’s dominance in AI inference.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop